Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes

Kimberly Page,1,2 Fares Qeadan,1,2 Clifford Qualls,2 Karla Thornton,1 Sanjeev Arora1 1Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA; 2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Page K, Qeadan F, Qualls C, Thornton K, Arora S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/3f4cf4f2ad994be5b536262d7aa5f9b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f4cf4f2ad994be5b536262d7aa5f9b1
record_format dspace
spelling oai:doaj.org-article:3f4cf4f2ad994be5b536262d7aa5f9b12021-12-02T11:41:58ZProject ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes1179-1535https://doaj.org/article/3f4cf4f2ad994be5b536262d7aa5f9b12019-10-01T00:00:00Zhttps://www.dovepress.com/project-echo-revisited-propensity-score-analysis-and-hcv-treatment-out-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Kimberly Page,1,2 Fares Qeadan,1,2 Clifford Qualls,2 Karla Thornton,1 Sanjeev Arora1 1Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA; 2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM, USACorrespondence: Kimberly PageDepartment of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 98131, USATel +1505-272-2520Email Pagek@salud.unm.eduAbstract: Propensity score analysis is a statistical approach to reduce bias often present in non-randomized observational studies. In this paper we use this method to re-analyze data from a study that assessed whether patients receiving HCV treatment from providers in Project ECHO had different clinical outcomes than patients treated by specialists from an academic medical center (UNM HCV clinic) but in which treatment assignment was not randomized. We modeled the best estimated probability of treatment assignment, and then assess differences overall SVR and SVR in patients with genotype 1 infection by treatment arm using Stabilized Inverse Probability of Treatment Weights (SIPTW). Results show that after adjustment for SIPTW, HCV treatment outcomes were significantly better for the ECHO patients compared to the UNM HCV clinic patients. Higher proportions of patients treated by primary care providers achieved SVR and SVR with genotype 1 compared to those treated at UNM HCV clinic with 15.1% and 16.3% absolute differences, respectively. These results indicate that previously published results (showing no differences) were biased, and resulted in an underestimation of the treatment effect of ECHO on HCV treatment.Keywords: propensity scoring, ECHO, hepatitis C virus, treatmentPage KQeadan FQualls CThornton KArora SDove Medical Pressarticlepropensity scoringECHOhepatitis C virustreatmentDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 11, Pp 149-152 (2019)
institution DOAJ
collection DOAJ
language EN
topic propensity scoring
ECHO
hepatitis C virus
treatment
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle propensity scoring
ECHO
hepatitis C virus
treatment
Diseases of the digestive system. Gastroenterology
RC799-869
Page K
Qeadan F
Qualls C
Thornton K
Arora S
Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
description Kimberly Page,1,2 Fares Qeadan,1,2 Clifford Qualls,2 Karla Thornton,1 Sanjeev Arora1 1Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA; 2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM, USACorrespondence: Kimberly PageDepartment of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 98131, USATel +1505-272-2520Email Pagek@salud.unm.eduAbstract: Propensity score analysis is a statistical approach to reduce bias often present in non-randomized observational studies. In this paper we use this method to re-analyze data from a study that assessed whether patients receiving HCV treatment from providers in Project ECHO had different clinical outcomes than patients treated by specialists from an academic medical center (UNM HCV clinic) but in which treatment assignment was not randomized. We modeled the best estimated probability of treatment assignment, and then assess differences overall SVR and SVR in patients with genotype 1 infection by treatment arm using Stabilized Inverse Probability of Treatment Weights (SIPTW). Results show that after adjustment for SIPTW, HCV treatment outcomes were significantly better for the ECHO patients compared to the UNM HCV clinic patients. Higher proportions of patients treated by primary care providers achieved SVR and SVR with genotype 1 compared to those treated at UNM HCV clinic with 15.1% and 16.3% absolute differences, respectively. These results indicate that previously published results (showing no differences) were biased, and resulted in an underestimation of the treatment effect of ECHO on HCV treatment.Keywords: propensity scoring, ECHO, hepatitis C virus, treatment
format article
author Page K
Qeadan F
Qualls C
Thornton K
Arora S
author_facet Page K
Qeadan F
Qualls C
Thornton K
Arora S
author_sort Page K
title Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
title_short Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
title_full Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
title_fullStr Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
title_full_unstemmed Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
title_sort project echo revisited: propensity score analysis and hcv treatment outcomes
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/3f4cf4f2ad994be5b536262d7aa5f9b1
work_keys_str_mv AT pagek projectechorevisitedpropensityscoreanalysisandhcvtreatmentoutcomes
AT qeadanf projectechorevisitedpropensityscoreanalysisandhcvtreatmentoutcomes
AT quallsc projectechorevisitedpropensityscoreanalysisandhcvtreatmentoutcomes
AT thorntonk projectechorevisitedpropensityscoreanalysisandhcvtreatmentoutcomes
AT aroras projectechorevisitedpropensityscoreanalysisandhcvtreatmentoutcomes
_version_ 1718395335991099392